In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

A Google Students mock interview video offers insights into how candidates are assessed in technical interviews at Google. The session demonstrates a coding problem involving finding the largest ...

Large language models (LLMs) aren’t actually giant computer brains. Instead, they are effectively massive vector spaces in which the probabilities of tokens occurring in a specific order is ...

Faculty members at Northeast Community College are beginning to integrate artificial intelligence tools into their classrooms ...

Google DeepMind CEO Demis Hassabis believes that the leading players in the artificial intelligence space are creating a self-reinforcing cycle of improvement. Speaking on the 20VC podcast, Hassabis ...

Silicon Valley’s timeline for "solving" human health is dangerously optimistic, but AI is quietly breaking pharma’s biggest ...

Experts at RSAC 2026 warned that AI is outpacing human defenders—forcing machines to take on both sides of the fight.

There is something almost disarmingly sincere about youth orchestras; an openness of gesture, a lack of defensive irony, that ...

CoinDesk Research maps five crypto privacy approaches and examines which models hold up as AI improves. Full coverage of ...

Major release delivers seamless Ignition SCADA, enterprise-grade security, advanced ML algorithms, and private cloud ...